{
    "nctId": "NCT04652609",
    "briefTitle": "Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program",
    "officialTitle": "Prevention of Chemotherapy-induced Peripheral Neuropathy With Therapeutic Exercise and Blood Flow Restriction Using PRESIONA Program",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Neoplasm",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 25,
    "primaryOutcomeMeasure": "Patient-reported CIPN symptoms",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 18 years or older\n* HER2+ breast cancer diagnosis\n* On the waiting list to anticancer medical treatment (taxanes-based neoadjuvant chemotherapy)\n\nExclusion Criteria:\n\n* Previous diagnosis of cancer\n* Pregnant\n* Cardiac pathology\n* No symptoms or pathology that could be confused with neuropathy or related to diabetes\n* No recommendation from oncologist for therapeutic exercise practice",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}